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TGF-β modulates immune response by suppressing non-regulatory
T (Treg) function and promoting Treg function. The question of
whether TGF-β achieves distinct effects on non-Treg and Treg cells
through discrete signaling pathways remains outstanding. In this
study, we investigated the requirements of Smad-dependent and
-independent TGF-β signaling for T-cell function. Smad2 and Smad3
double deficiency in T cells led to lethal inflammatory disorder in
mice. Non-Treg cells were spontaneously activated and produced
effector cytokines in vivo on deletion of both Smad2 and Smad3.
In addition, TGF-β failed to suppress T helper differentiation effi-
ciently and to promote induced Treg generation of non-Treg cells
lacking both Smad2 and Smad3, suggesting that Smad-dependent
signaling is obligatory to mediate TGF-β function in non-Treg cells.
Unexpectedly, however, the development, homeostasis, and func-
tion of Treg cells remained intact in the absence of Smad2 and
Smad3, suggesting that the Smad-independent pathway is impor-
tant for Treg function. Indeed, Treg-specific deletion of TGF-β–acti-
vated kinase 1 led to failed Treg homeostasis and lethal immune
disorder in mice. Therefore, Smad-dependent and -independent
TGF-β signaling discretely controls non-Treg and Treg function to
modulate immune tolerance and immune homeostasis.
inflammation | immune-suppression
TGF-β is a pleiotropic cytokine critical for immune regulation(1). The most prominent role of TGF-β in immune regulation is
to suppress immune response, because deletion of TGF-β leads to
lethal autoimmune syndrome in mice (2). TGF-β is central to
suppressing T-cell function because the deletion of TGF-β receptor
(TGF-βR) specifically in T cells results in lethal autoimmunity
reminiscence of TGF-β1 deficiency (1, 3). TGF-β controls T-cell
function through multiple mechanisms. It inhibits T-cell prolifer-
ation and T-cell differentiation (4). In addition, TGF-β is important
for the generation of Foxp3-expressing immune-suppressive regu-
latory T cells. TGF-β signaling is required for the development of
naturally occurring regulatory T (nTreg) cells in the thymus (5, 6),
potentially by promoting their survival (7). In addition, TGF-β
promotes the generation of induced regulatory T (iTreg) cells
through promoting Foxp3 expression in activated non-Treg cells (8,
9). Therefore, TGF-β controls T-cell response by multiple means
through Treg-dependent and -independent mechanisms.
Binding of TGF-β to TGF-βR activates structurally similar
transcription factors Smad2 and Smad3 in the target cells (10, 11).
Activated Smad2 or Smad3 heterodimerizes with Smad4 and
translocates into the nucleus to regulate target gene expression.
Smad-independent pathways also exist to mediate TGF-βR sig-
naling (12). TGF-β induces rapid activation of TGF-β–activated
kinase 1 (TAK1), Ras-Erk, and PI3K-Akt pathways.
Although the importance of TGF-β in controlling T-cell
function is undeniable, it remains poorly understood as to what
intracellular components are critical to mediate its function in
target cells. More importantly, it is unclear as to whether Treg-
dependent and -independent functions of TGF-β can be attrib-
uted to different signaling pathways downstream of TGF-βR.
Efforts have been devoted to study the involvement of Smad
proteins in T-cell function. T cells deficient in Smad3 or Smad2
are normal in development and homeostasis (13, 14), displaying
distinct phenotypes from the mice whose T cells lack TGF-βR
(3, 5, 6). These findings suggested that Smad-dependent path-
ways may be dispensable for TGF-β–mediated effects in T cells.
Yet, a recent report showed that deficiency of both Smad2 and
Smad3 in T cells led to development of autoimmunity in mice
(15). When both Smad2 and Smad3 were deleted during early
T-cell development, T-cell thymic development was impaired
and peripheral T cells were aberrantly activated, associating with
reduced Treg numbers. These findings suggest that Smad2 and
Smad3 are redundantly required to control the functions of both
non-Treg cells and Treg cells. Nevertheless, such observation
could be confounded by the drastic defect in T-cell development,
and thereby central tolerance. Thus, the question of whether
Smad2 and Smad3 are essential for the normal functions of
mature T cells remains outstanding.
Results
CD4Cre:Smad2fl/fl:Smad3−/− (CD4:DKO) Mice Developed Lethal Inflam-
mation.To address whether Smad2 and Smad3 are essential for the
normal function of mature T cells, we crossed CD4Cre transgenic
mice (16) with Smad2fl/fl and Smad3−/− mice to obtain CD4Cre:
Smad2fl/fl:Smad3−/− [CD4:DKO (double KO)] mice. Although
CD4Cre:Smad2fl/fl and Smad3−/− mice were viable and phenotyp-
ically grossly normal (13, 15, 17) (Fig. S1), CD4:DKO mice suc-
cumbed to an inflammatory disorder by 4 wk of age (Fig. 1A).
Compared with WT littermates, CD4:DKO mice were sub-
stantially smaller in size (Fig. 1B). Nonetheless, comparable
numbers of lymphocytes from CD4:DKO mice and the WT lit-
termates were recovered from the peripheral lymph nodes (PLNs)
and spleens (Fig. 1C). Immune pathological findings were detec-
ted in the nonlymphoid organs, such as the intestines, from CD4:
DKO mice (Fig. 1D).
Phenotypic Characterization of T Cells from CD4:DKO Mice. To
understand the cellular mechanisms underlying the observed
immune disorder in CD4:DKO mice, we characterized the
phenotypes of thymic and peripheral T cells from these mice. We
first confirmed that Smad2 and Smad3 were efficiently deleted in
the mature T cells as well as in the majority of the thymocytes
from CD4:DKO mice (Fig. 2A). In the thymus, the distribution of
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different thymocyte populations in CD4:DKO mice was compa-
rable to that observed in the WT littermates (Fig. 2B). In addi-
tion, thymocyte development in CD4:DKO mice was largely
normal, because the expression of thymocyte maturation and
activation markers, such as CD5, CD24, and CD69, was similar
between CD4:DKO mice and WT mice (Fig. S2). In addition, the
distribution of mature CD4 and CD8 T-cell populations in the
PLNs and spleens was comparable between CD4:DKO and WT
mice (Fig. 2B). Nevertheless, CD4 non-Treg cells and CD8 T
cells from CD4:DKO mice displayed activated phenotypes with
down-regulation of CD62L expression and up-regulation of
CD44 expression (Fig. 2C). CD4:DKO T cells predominantly
acquired T helper (TH) 1 function because a great number of
T cells from CD4:DKO mice produced TH1 signature cytokine
IFN-γ (18, 19) but less TH2 signature cytokine IL-4 (18, 19) or
TH17 signature cytokine IL-17A (20, 21) (Fig. 2D and Fig. S3).
These findings are similar to the previous reports showing that
disruption of TGF-βR in T cells led to a dominant TH1 response
in mice (3, 5). We further investigated whether the Treg pop-
ulation was perturbed when Smad2 and Smad3 were deficient.
Unexpectedly, the percentages of Foxp3+ Treg cells were not
decreased in the thymus, PLNs, or spleens (Fig. 2E). These
findings suggest that both Smad2 and Smad3 are required to
suppress the activation and effector function of non-Treg cells yet
are not essential for Treg homeostasis.
Cell-Intrinsic Defects of Non-Treg Cells Lacking Smad2 and Smad3.
CD4:DKO mice developed lethal inflammation. Treg number
may be aberrantly up-regulated under inflammatory conditions
(6, 22–24). Thus, the inflammatory condition existing in CD4:
DKO mice may mask potential Treg defects and confound the
T-cell phenotypes observed. We therefore evaluated the cell-
intrinsic effects of Smad2 and Smad3 deletion on T-cell function
by generating mixed bone marrow chimeric mice, where WT and
CD4:DKO T cells were compared directly in the same host. Equal
numbers of bone marrow cells from CD45.2+ CD4:DKO mice
and CD45.1+ WT mice were mixed and then transferred into
irradiated Rag1−/− recipients. In the thymus of reconstituted
recipients, the percentages of different thymocyte subsets were
comparable between CD4:DKO and WT cells (Fig. 3A). The
developmental markers were similarly expressed on CD4:DKO
thymocytes and their WT counterparts (Fig. S4). In addition,
mature CD4 and CD8 T cells of CD4:DKO origin were efficiently
generated in the periphery (Fig. 3A). Moreover, similar percent-
ages of Foxp3+ Treg cells of CD4:DKO and WT origins were
found in the thymus, PLNs, and spleens of the recipients (Fig.
3B). Therefore, the development and peripheral maintenance of
CD4:DKO T cells were largely normal. Nonetheless, although
coexisting WT CD4 non-Treg and CD8 T cells displayed a naive
phenotype, CD4:DKO CD4 non-Treg and CD8 T cells showed an
activated phenotype (CD62LlowCD44high) (Fig. 3C and Fig. S5A).
In addition, compared with coexisting WT CD4 non-Treg and
CD8 T cells, wherein minimal effector cytokines were produced,
CD4:DKO CD4 and CD8 T cells produced increased amounts of
effector cytokines (Fig. 3D and Fig. S5B). These findings suggest
that Smad2- and Smad3-deficient non-Treg cells are intrinsically
prone to spontaneous activation and differentiation in vivo in the

















































Fig. 1. CD4:DKO mice developed lethal inflammation. (A) Comparison of
the survival rates between CD4:DKO (dashed line) and WT (solid line) mice
after birth. (B) Size comparison between a 3-wk-old CD4:DKO mouse and its
sex- and age-matched WT littermate. The result is representative of at least
three experiments. (C) Numbers of total lymphocytes recovered from the
thymus, PLNs, and spleens of 3-wk-old WT (open bars) and CD4:DKO (solid
bars) mice. The mean ± SD of the results from four pairs of mice are shown.
(D) H&E staining and histological analysis of the intestines isolated from WT


































































































































Fig. 2. Phenotypic characterization of T cells from CD4:DKO mice. (A) Effi-
cient Smad2 and Smad3 deletion in T cells. Thymocytes and peripheral CD4 T
cells were isolated from WT, CD4Cre:Smad2fl/fl (S2KO), Smad3−/− (S3KO), and
CD4Cre:Smad2fl/fl:Smad3−/− (CD4:DKO) mice. The protein expression of
Smad2 and Smad3 in isolated cells was detected by immunoblotting. β-Actin
expression was also detected as loading controls. Results are representative
of three experiments. (B) Distribution of T-cell populations. Lymphocytes
were isolated from the thymus, PLNs, and spleens of WT and CD4:DKO mice.
The distribution of CD4 and CD8 T cells in the recovered lymphocytes was
assessed by flow cytometric analysis. Representative results from three
experiments are shown. (C) Activation of T cells. Lymphocytes were isolated
from the PLNs and spleens of WT and CD4:DKO mice. CD62L and CD44 ex-
pression on CD4 and CD8 T cells was assessed by flow cytometric analysis.
Results are representative of at least three experiments. (D) Effector cyto-
kine production of T cells. Lymphocytes were isolated from the PLNs and
spleens of WT and CD4:DKO mice. IFN-γ, IL-4, and IL-17A production by CD4
T cells was assessed by flow cytometric analysis. Results are representative of
at least three experiments. (E) Distribution of Treg cells. Foxp3-expressing
Treg cells among CD4 single-positive T-cell populations in the thymus, PLNs,
and spleens were detected by flow cytometric analysis. Representative
results from at least three experiments are shown.
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Evaluation of the Function of CD4:DKONon-Treg and Treg Cells in Vitro.
The spontaneous T-cell activation and effector cytokine pro-
duction of CD4:DKO CD4 T cells are likely attributable to the
enhanced ability of these cells to differentiate into effector T cells.
We thus compared the ability of WT and CD4:DKO CD4 T cells
to differentiate into TH1 and TH2 cells under polarizing con-
ditions. Because naive CD4 T cells could hardly be obtained from
CD4:DKO mice, we sorted CD25−CD62LhighCD44low naive CD4:
DKO and WT CD4 T cells from bone marrow chimeric mice as
described in Fig. 3. Purified cells were activated under nonpo-
larizing (TH0) as well as TH1 and TH2 polarizing conditions.
TH1 and TH2 differentiation of CD4 T cells was assessed 4 d
after activation. Higher percentages of IFN-γ–expressing cells
were detected in CD4:DKO cells than in WT cells under TH0 and
TH1 conditions. Higher percentages of IL-4–expressing cells were
detected in CD4:DKO cells than in WT cells under TH0 and TH2
conditions (Fig. 4A). Therefore, in the absence of Smad2 and
Smad3, T cells displayed enhanced ability to differentiate into
effector TH cells.
Because Smad2 and Smad3 are involved in the TGF-β signaling
that is important to suppress TH differentiation and to promote
Foxp3 expression in activated T cells (4, 8, 9), we hypothesized that
CD4:DKOT cells were refractory to TGF-β–mediated inhibition of
TH differentiation and TGF-β–promoted iTreg generation. In-
deed, although addition of exogenous TGF-β potently inhibited
TH1 and TH2 differentiation of WT T cells, such effects of TGF-β
were greatly reduced in CD4:DKO T cells (Fig. 4A). In addition,
TGF-β–promoted iTreg generation was impaired in CD4:DKO
T cells (Fig. 4B). These findings suggest that Smad2 and Smad3 are
required for TGF-β–mediated suppression of non-Treg cells as well
as TGF-β–promoted conversion of non-Treg cells to Treg cells.
Although we have found that Smad2 and Smad3 were not re-
quired for the generation and maintenance of Treg cells (Figs. 2
and 3), whether the suppressive function of CD4:DKO is intact
remains to be addressed. To answer this question, we performed
in vitro T-cell suppression assays as previously described (25).
CD4+CD25+ Treg cells were sorted fromCD4:DKOmice andWT
littermates as “suppressor T cells.” Carboxylfluorescein succini-
midylester-labeled WT CD25−CD45RBhi CD4 non-Treg cells
were used as “responder T cells.” CD4:DKO Treg cells suppressed
proliferation of responder T cells as efficiently as, if not more
efficiently than, WT Treg cells, suggesting that CD4:DKO Treg
cells possess intact immune suppressive function (Fig. 4C).
Treg Homeostasis and Function in Mice with Treg-Specific Double
Deletion of Both Smad2 and Smad3. TGF-β is required for the pe-
ripheral maintenance of Treg cells (5, 26). Whether the Smad-
dependent or -independent pathway mediates TGF-β–promoted
Treg maintenance remains unclear. Our aforementioned findings
suggest that Smads may not be essential for Treg generation
and function. To investigate further the specific requirements of

























































































































Fig. 3. Cell-intrinsic defects of T cells lacking Smad2 and Smad3. Bone
marrow cells isolated from WT (CD45.1+) and CD4:DKO (CD45.2+) mice were
mixed at a 1:1 ratio. Cell mixtures were transferred into sublethally irradi-
ated Rag1−/− mice. Eight weeks after transfer, T cells from reconstituted,
mixed bone marrow chimeric mice were analyzed. (A) Distributions of CD4 T,
CD8 T, and CD4−CD8− cells generated from the bone marrow cells of WT
(CD45.1+) and CD4:DKO (CD45.2+) mice were determined by flow cytometric
analysis. (B) Foxp3-expressing Treg cells among CD4 single-positive T-cell
populations in the thymus, PLNs, and spleens were detected by flow cyto-
metric analysis. The cells originating from WT (CD45.1+) and CD4:DKO
(CD45.2+) mice were distinguished by congenic markers CD45.1 and CD45.2,
respectively. (C) Lymphocytes were isolated from the PLNs and spleens of
mixed bone marrow chimeric mice. CD62L and CD44 expression on CD4 T
cells originating from WT (CD45.1+) and CD4:DKO (CD45.2+) mice was
assessed by flow cytometric analysis. (D) Lymphocytes were isolated from the
PLNs and spleens of mixed bone marrow chimeric mice. IFN-γ, IL-10, IL-4, and
IL-17A production by CD4 T cells originating from WT (CD45.1+) and CD4:
DKO (CD45.2+) mice was assessed by flow cytometric analysis. Results shown
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Fig. 4. Evaluation of the function of CD4:DKO T cells in vitro. (A) WT
(CD45.1+) and CD4:DKO (CD45.2+) CD25−CD62LhighCD44low naive CD4 T cells
were purified from the mixed bone marrow chimeric mice described in Fig. 3.
Purified cells were activated with plate-bound anti-CD3 and anti-CD28 mAb
under nonpolarizing (TH0) and TH1 or TH2 polarizing conditions in the
presence (+) or absence (−) of exogenous recombinant TGF-β. IFN-γ and IL-4
production was assessed by intracellular cytokine staining and flow cytometric
analysis. Results are representative of three experiments. (B) WT (CD45.1+)
and CD4:DKO (CD45.2+) CD25−CD62LhighCD44low naive CD4 T cells were pu-
rified from the mixed bone marrow chimeric mice described in Fig. 3. Purified
cells were activated with plate-bound anti-CD3 and anti-CD28 mAb in the
presence (+) or absence (−) of TGF-β. The generation of iTreg cells was de-
termined by Foxp3 intracellular staining and flow cytometric analysis. Results
are representative of three experiments. (C) CD4+CD25+ Treg cells were sorted
from WT (dashed line, open diamonds) and CD4:DKO (solid line, open
squares) mice. An in vitro T-cell suppression assay was performed. (Left)
Proliferation of responder T cells was assessed by carboxyfluorescein succini-
midylester (CFSE) dilution. Results are representative of three experiments.
(Right) Mean division index ± SD of three samples in one experiment rep-
resentative of three are plotted.









physiological conditions, we generated mice with Treg-specific
Smad2 and Smad3 double deficiency. Smad2fl/fl and Smad3−/−
mice were crossed with Foxp3-EGFP-Cre (FGC) transgenic mice,
where a BAC transgenic construct encoding both EGFP and Cre
under the control of Foxp3 promoter was inserted into mouse
genome (27). Thus, in FGC:Smad2fl/fl:Smad3−/− mice (hereafter
referred to as FGC:DKO mice), only Foxp3-expressing Treg cells
are deficient in both Smad2 and Smad3. FGC:DKO mice were
grossly normal. The development and homeostasis of T cells of
FGC-DKO mice were comparable to those of WT littermates
(Fig. 5A). In addition, minimal activation (Fig. 5B) and cytokine
production (Fig. 5C) were detected in non-Treg cells from FGC:
DKO mice. These findings suggest that Smad2 and Smad3 de-
letion in Treg cells did not compromise immune homeostasis.
Further analysis revealed that Treg cells were efficiently gener-
ated in the thymus and maintained in the periphery of FGC:DKO
mice (Fig. 5D). A modestly higher percentage of Treg cells was
detected in FGC:DKO mice compared with WT littermates. In
addition, compared with WT Treg cells, Treg cells in FGC:DKO
mice expressed normal levels of Treg signature genes, including
cytotoxic T-lymphocyte antigen 4 (CTLA-4) and glucocorticoid-
induced TNFR-related protein (GITR) (Fig. 5E). Moreover,
compared with WT Treg cells, FGC:DKO Treg cells suppressed
naive T-cell proliferation in vitro (Fig. 5F) and inhibited naive
T cell-elicited inflammatory bowel disease (IBD) in vivo (Fig.
5G) to a similar extent. These findings suggest that Smad2 and
Smad3 are dispensable for Treg function.
TAK1 Is Essential for Treg Homeostasis. Smad-independent pathways
are also involved in TGF-β signaling (12, 28). TAK1 can be ac-
tivated by TGF-β independent of Smads (29) and is important for
T-cell development, function, and survival (30). Whether and how
TAK1 is involved in Treg function have not been addressed. We
hypothesized that TAK1-mediated signaling is critical for the
maintenance of Treg cells. To test this hypothesis, we crossed
TAK1fl/fl mice (31) with FGC mice to delete TAK1 specifically in
Treg cells. FGC:TAK1fl/fl mice succumbed to an inflammation
disorder by 6 wk of age. FGC:TAK1fl/fl mice developed lymph-
adenopathy and splenomegaly. In agreement with this observa-
tion, the total numbers of lymphocytes recovered from the PLNs
and spleens of FGC:TAK1fl/fl mice were higher compared with
those from WT littermates (Fig. 6A). In addition, non-Treg CD4
T cells and CD8 T cells in FGC:TAK1fl/fl mice displayed an ac-
tivated phenotype (Fig. 6B) with increased production of effector
cytokines (Fig. 6C). These findings suggested a defect in Treg
population. Indeed, the numbers of Foxp3-expressing Treg cells
were significantly reduced in FGC:TAK1fl/fl mice (Fig. 6D). A
closer examination revealed that the remaining Treg cells in FGC:
TAK1fl/fl mice are “escaping” Treg cells failing to express functional
Cre, because when FGC:TAK1fl/fl mice were crossed with Cre-re-
porter mice, where YFP is expressed only when functional Cre is
present in the cells, few YFP cells could be detected in these mice
(Fig. S6). This observation suggests that TAK1 is essential for Treg
homeostasis. To validate this finding further and to study the cell-
intrinsic defects of TAK-deficient Treg cells, we generated mixed
bone marrow chimeric mice to compare TAK1-deficient and
-sufficient Treg cells in the same hosts. Equal numbers of bone
marrow cells from FGC:TAK1fl/fl mice (45.1.2) and WT mice
(45.2.2) were mixed and transferred into irradiated Rag1−/−
recipients. The contribution of the Treg population from different
donor origins was determined 8 wk after transfer. Although 10–
20% of WT CD4 T cells expressed Foxp3, ∼2% of FGC:TAK1fl/fl
CD4 T cells expressed Foxp3 in the chimeric mice. Therefore,
TAK1 is essential for homeostasis of Treg cells.
Discussion
TGF-βR signaling cascades are complex, involving Smad-depen-
dent and -independent pathways. The question remains as to
whether the diverse function of TGF-β is differentially mediated
through discrete signaling pathways. Using genetic approaches, we
investigated this issue. Our results suggest that Smad-dependent
pathways are obligatory to suppress the activation and TH dif-
ferentiation of non-Treg cells and to maintain immune homeo-
stasis. In addition, Smads are required for TGF-β–mediated
immune suppression in T cells and for TGF-β–promoted iTreg
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Fig. 5. Normal Treg homeostasis and function in mice with Treg-specific
double deficiency of Smad2 and Smad3. (A) Distribution of CD4 and CD8 T
cells in the thymus, PLNs, and spleens of WT and FGC:DKO mice, wherein
both Smad2 and Smad3 were deleted specifically in Treg cells. Representa-
tive results from three experiments are shown. (B) Activation of CD4 and
CD8 T cells in the PLNs and spleens of WT and FGC:DKOmice was assessed by
CD62L and CD44 staining and flow cytometric analysis. Results are represen-
tative of three experiments. (C) Effector cytokine production by CD4 and CD8
T cells in the PLNs and spleens of WT (solid lines) and FGC:DKO (dashed lines)
mice was assessed by intracellular cytokine staining and flow cytometric
analysis. The percentages of cytokine-producing cells are indicated above the
brackets. Representative results of three experiments are shown. (D) Percen-
tages of Foxp3+ Treg cells among CD4 single-positive T cells in the PLNs,
spleens, and thymus of WT and FGC:DKO mice were determined by in-
tracellular staining and flow cytometric analysis. The mean ± SD of three pairs
of mice are shown. (E) Flow cytometric analysis of coexpression of cytotoxic
T-lymphocyte antigen 4 (CTLA-4), glucocorticoid-induced TNFR-related pro-
tein (GITR) with Foxp3 in Treg cells from the PLNs, spleens, and thymus of WT
and FGC:DKO mice. Results are representative of three experiments. (F) GFP+
Treg cells were sorted from WT (dashed line) or FGC:DKO (solid line) mice. An
in vitro T-cell suppression assay was performed. The mean division index ± SD
of three samples in one experiment representative of three are plotted. (G)
GFP+ Treg cells were sorted from WT (solid line) or FGC:DKO (dashed line)
mice. Treg-mediated protection of naive CD4+ T cell-elicited inflammatory
bowel disease (IBD) was assessed. The body weight changes of recipient mice
were recorded. The mean ± SD of five mice in one experiment representative
of two are shown.
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generation. Therefore, Smads are likely the dominant factors
mediating the TGF-β effect on non-Treg cells. In contrast, Smad2
and Smad3 deficiency did not noticeably affect the generation,
homeostasis, or function of thymic-derived Treg cells, whereas
deletion of TAK1, a critical component of the Smad-independent
pathway, abrogated Treg homeostasis, suggesting that TGF-β
controls Treg homeostasis through Smad-independent pathways.
These findings support the notion that Smad-dependent and
-independent pathways mediate discrete T-cell functions (Fig.
S7). By carrying out distinct functions, Smad-dependent and
-independent pathways cooperate to mediate TGF-β–controlled
self-tolerance and immune homeostasis through Treg-dependent
and -independent mechanisms.
Although nTreg and iTreg cells are both immune-suppressive,
they are distinct in certain aspects. For instance, Foxp3 expression
is more stable in nTreg cells than in iTreg cells (32–34), and the
genetic program and epigenetic modification of gene loci of nTreg
and iTreg cells are different (35–37), suggesting that the genera-
tion and maintenance of nTreg and iTreg cells may be mediated
through distinct mechanisms. We have found that Smads are re-
quired for the generation of iTreg cells but not for the generation
of nTreg cells, indicating that Smad signaling may be critically
involved in the genetic and/or epigenetic distinction between
nTreg and iTreg cells.
Being able to integrate signals from multiple stimuli is a com-
mon and useful feature of intracellular signaling transducers. Such
ability allows signal transducers to sense different environment
cues and to integrate and translate such cues into appropriate
responses. As intracellular signal transducers, Smad2 and Smad3
predominantly mediate TGF-β signaling in T cells. It is never-
theless recognized that Smad2 and Smad3 can relay signaling of
other TGF-β superfamily members, such as activins (38). Similarly,
TAK1 can mediate signals not only from TGF-β but from T-cell
receptor and other cytokines in T cells (30). Thus, the defects
observed in T cells lacking Smad2, Smad3, and TAK1 could be the
combined effects of abrogation of TGF-β and other signaling
pathways. Although it remains to be revealed howmuch the effects
of Smad deletion and/or TAK1 deletion on T cells can be attrib-
uted to the defects in TGF-β–dependent or –independent signals,
this study provides genetic evidence to suggest that Smad-depen-
dent and -independent pathways control distinct functions in dif-
ferent T-cell types, and thus offer unique insights into how pleio-
tropic effects of TGF-β on T cells could be mediated.
Deletion of Smad2 and Smad3 during the early [double-nega-
tive (DN)] stage of thymic development using LckCre resulted in
drastic alternation of T-cell development (15). However, we
found that thymocyte development was largely unperturbed when
Smad2 and Smad3 were deleted at the later [double-positive
(DP)] stage of T-cell development using CD4Cre. The reason for
defective thymocyte development in Lck:DKO mice is unlikely to
be attributable to inflammation because lethal inflammation de-
veloped in both models. Therefore, these findings suggest a criti-
cal role for Smads during the DN-to-DP transition in T-cell







































































































Fig. 6. TAK1 is essential for the homeostasis of Treg cells. (A) Numbers of lymphocytes in the PLNs, spleens, and thymus of WT and FGC:TAK1 mice, wherein
TAK1 was specifically deleted in Treg cells. The mean ± SD of three pairs of mice are shown. *P < 0.05; NS, nonsignificant. (B) Activation of CD4 and CD8 T cells
in the PLNs and spleens of WT and FGC:TAK1mice was assessed by CD62L and CD44 staining and flow cytometric analysis. Results are representative of at least
three experiments. (C) Effector cytokine production by CD4 and CD8 T cells in the PLNs and spleens of WT and FGC:TAK1 mice was assessed by intracellular
cytokine staining and flow cytometric analysis. Results are representative of at least three experiments. (D) Percentages of Foxp3+ Treg cells among CD4
single-positive T cells in the PLNs, spleens, of WT and FGC:TAK1 mice were determined by intracellular staining and flow cytometric analysis. The values
are indicated above the brackets. Representative results from at least three experiments are shown. (E) Equal numbers of bone marrow cells isolated from
WT (CD45.2.2) and FGC:TAK1 (CD45.1.2) mice were transferred into sublethally irradiated Rag1−/− recipient mice. Eight weeks after transfer, CD4 T cells
were isolated from the recipient mice. The percentages of Foxp3+ Treg cells of different origins were determined by flow cytometric analysis. The values are
indicated above the brackets. Results representative of at least three experiments are shown.









mice, the generation of thymic Treg cells was defective, suggest-
ing that the expression of Smad2 and Smad3 during the DN stage
but not the DP stage of thymocyte development is essential for
the induction of Treg cells. Therefore, Smad-dependent pathways
may be required for the development of T cells at specific stage(s)
in the thymus. Considering the fact that T-cell thymic selection
establishes central tolerance, whether and how Smad-dependent
pathways may regulate self-tolerance by modulating thymic se-
lection of non-Treg and Treg cells are remaining questions to
be addressed.
Materials and Methods
Mice. SMAD3−/−, SMAD2fl/fl, TAK1fl/fl, CD4Cre, FGC, Rag1−/−, YFP Cre reporter,
and CD45.1 mice were kept under specific pathogen-free conditions in the
animal care facility at the University of North Carolina. All mouse experiments
were approved by the Institutional Animal Care and Use Committee of the
University of North Carolina.
Cell Function Analysis in Vitro and in Vivo. T-cell isolation, activation, differ-
entiation, flow cytometric analysis, cell sorting, in vitro and in vivo suppres-
sion assays, and bone marrow chimera generation were performed as
described previously (39). Details are provided in SI Materials and Methods.
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